Log in

CNSX:BAMMBody and Mind Stock Price, Forecast & News

$0.51
+0.01 (+2.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.48
Now: $0.51
$0.50
50-Day Range N/A
52-Week Range N/A
Volume77,096 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Body and Mind Inc., a development stage company, produces medical and recreational marijuana. The company offers packaged and grinded flower buds; concentrates; disposable pen vaporizers; distillate oil cartridges; and distillate infused edible products. It produces and sells cannabis flowers, oil extracts, and edibles under the Body and Mind brand name through licensed dispensaries in Nevada. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was founded in 1998 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone604-376-3567

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive BAMM News and Ratings via Email

Sign-up to receive the latest news and ratings for BAMM and its competitors with MarketBeat's FREE daily newsletter.

Body and Mind (CNSX:BAMM) Frequently Asked Questions

Has Body and Mind been receiving favorable news coverage?

News articles about BAMM stock have been trending somewhat negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Body and Mind earned a news impact score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutBody and Mind.

Who are some of Body and Mind's key competitors?

What other stocks do shareholders of Body and Mind own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Body and Mind investors own include Cresco Labs (CRLBF), Curaleaf (CURLF), iAnthus Capital (ITHUF), Planet 13 (PLNHF), Acreage (ACRGF), Arena Pharmaceuticals (ARNA), Ayr Strategies (AYRSF), Canopy Growth (CGC), Cronos Group (CRON) and OTCMKTS:CRTPF (CRTPF).

Who are Body and Mind's key executives?

Body and Mind's management team includes the following people:
  • Mr. Dong Hyun Shim C.P.A., B.B.A., CA, CPA, (Illinois), CFO & Director (Age 36, Pay $50k)
  • Mr. Stephen August Hoffman, COO & Director (Age 54, Pay $168.14k)
  • Mr. Darren Tindale, Corp. Sec. (Age 47, Pay $82.5k)
  • Mr. Michael Mills, CEO, Pres & Director (Age 51)
  • Mr. Harjit S. Grewal, VP of Corp. Devel. (Age 45)

What is Body and Mind's stock symbol?

Body and Mind trades on the CNSX under the ticker symbol "BAMM."

How do I buy shares of Body and Mind?

Shares of BAMM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Body and Mind's stock price today?

One share of BAMM stock can currently be purchased for approximately $0.51.

What is Body and Mind's official website?

The official website for Body and Mind is www.bamcannabis.com.

How can I contact Body and Mind?

The company can be reached via phone at 604-376-3567.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.